This study is a clinical trial funded by the Tourette Syndrome Association USA. The protocol uses repetitive transcranial magnetic stimulation to treat patients with moderate - severe tic disorder/Tourette Syndrome. This study is registered with ClinicalTrials.gov
Funding Source: Tourette Syndrome Association USA
This NIH-funded study assesses and compares motor skill development in children ages 8 to 12 years old with ADHD as well as typically developing children. We are using transcranial magnetic stimulation (TMS) to identify abnormalities in brain excitability that correlate with ADHD symptoms.
Funding: National Institutes of Health R01 MH078160
Collaborator: Stewart Mostofsky, MD, Laboratory for Neurocognitive and Imaging Research, Baltimore
This NIH-funded study is evaluating motor cortex changes related to treatment with atomoxetine for ADHD symptoms in children. We are using TMS to study the brain before treatment and after one month of treatment with atomoxetine.
Funding: NIH R01 MH08185
Collaborator: Randy Sallee, MD, PhD, University of Cincinnati
This study is funded by the Tourette Syndrome Association USA and evaluates a long-term potentiation-like property in children and adults with Tourette syndrome. We are using a new TMS technique to study brain changes related to learning in the motor system in children and adults with Tourette syndrome as well as healthy children and adults.
Funding: Tourette Syndrome Association USA
Utilizing tDCS to reduce auditory hallucinations in early onset schizophrenia (EOS). The protocol uses transcranial direct current stimulation (tDCS) to treat patients with refractory schizophrenia in an open-label treatment study.
This study broadly assesses differences in cortical excitability across different pediatric populations, including Autism Spectrum Disorder, typically developing children and other populations.
Funding Source: Movement Disorders Fund